<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03255798</url>
  </required_header>
  <id_info>
    <org_study_id>GCF-041</org_study_id>
    <nct_id>NCT03255798</nct_id>
  </id_info>
  <brief_title>A Prospective Evaluation of Glaucoma Subjects Treated With Two Second Generation iStents and One iStent Supra</brief_title>
  <acronym>GCF-041</acronym>
  <official_title>A Prospective Evaluation of Mild to Moderate Open-Angle Glaucoma Subjects Treated With Two Second Generation Micro-bypass Stents and One Suprachoroidal Stent</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Glaukos Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Glaukos Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective Evaluation of Open-Angle Glaucoma Subjects treated with two second generation
      iStents and one iStent Supra
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective Evaluation of Mild to Moderate Open-Angle Glaucoma Subjects treated with Two
      Second Generation Microbypass Stents and One Suprachoroidal Stent
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2017</start_date>
  <completion_date type="Anticipated">June 2020</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>G2 and G3</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>IOP outcome is masked</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>20% IOP reduction</measure>
    <time_frame>Month 12</time_frame>
    <description>IOP reduction observed compared to baseline IOP, measured by Goldmann tonometry in mm Hg</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>IOP less than or equal to 18 mm Hg</measure>
    <time_frame>Month 12</time_frame>
    <description>IOP compared to baseline IOP, measured by Goldmann tonometry in mm Hg</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Glaucoma, Open-Angle</condition>
  <arm_group>
    <arm_group_label>G2 and G3 implantation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Two iStent inject stents and one iStent Supra stent</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>G2 and G3</intervention_name>
    <description>Two iStent inject devices and one iStent supra device</description>
    <arm_group_label>G2 and G3 implantation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Phakic or pseudophakic subjects with posterior chamber IOLs Primary open-angle
             glaucoma or pseudoexfoliative glaucoma diagnosis Subject on two ocular hypotensive
             medications Medicated screening IOP greater than or equal to 18 mm Hg and less than or
             equal to 30 mm Hg Visual field or optic nerve defect characteristic of glaucoma Normal
             iridocorneal angle anatomy Absence of peripheral anterior synechiae Mean diurnal IOP
             at baseline between 21 and 45 mm Hg

        Exclusion Criteria:

          -  Subjects with anterior chamber IOLs Prior SLT or stent implantation in study eye
             Traumatic, uveitic, or neovascular glaucoma Fellow eye BCVA worse than 20/200
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeff Wells, PharmD</last_name>
    <role>Study Director</role>
    <affiliation>Glaukos Corporation</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jeff Wells, PharmD</last_name>
    <phone>949-482-0042</phone>
    <phone_ext>1227</phone_ext>
    <email>jwells@glaukos.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Harald Fuchs, PhD</last_name>
    <email>hfuchs@glaukos.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Fritz Hengerer, MD</name>
      <address>
        <city>Heidelberg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fritz Hengerer, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 17, 2017</study_first_submitted>
  <study_first_submitted_qc>August 17, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 21, 2017</study_first_posted>
  <last_update_submitted>December 14, 2017</last_update_submitted>
  <last_update_submitted_qc>December 14, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 18, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
    <mesh_term>Glaucoma, Open-Angle</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

